1、代表性项目
(1)国家自然科学基金青年基金,主持
(2)四川省科技厅青年基金,主持
2、代表性论文
(1)Z.M. Tang*, K.L. Chen, Y.D. Wang, Y.N. Ou, W.X. Liao, J.B. Song, Y.H. Xiang, D.L. Liu, Q.Y. Jin. A novel cascade enzyme/Fenton reaction approach for enhanced chemodynamic and starvation therapy. Journal of Colloid and Interface Science, 2026, 722, 140890 (1区,IF, 9.7)
(2)Z.M. Tang*, Y.N. Ou, Y.D. Wang, K.L. Chen, W.X. Liao, J.B. Song, Y.H. Xiang, P.J. Zhong, D.L. He, D.L. Liu, Q.Y. Jin. A dual responsive hydrogel with a single-atom copper nanodrug for precision and sustained tumor therapy. Journal of Materials Chemistry B, 2026.14(13):4144-4157. (3区, IF: 6.2)
(3)Y.D. Wang, K.L. Chen, Y.N. Ou, W.X. Liao, Y.Z. Liu, J.J. Wei, Q.Y. Jin, Z.M. Tang*. A TME-responsive nanocatalytic platform for synergistically enhanced chemodynamic therapy through calcium overload for precision cancer treatment. Carbon, 2025, 245, 120833. (2区, IF:12.6)
(4)Z.M. Tang*, Y.D. Wang, K.L. Chen, Y.N. Ou, W.X. Liao, P.J. Zhong, H.Z. Wei, Q.Y. Jin. Thiosulfate enhanced Fenton-like nanocatalyst for synergistic chemodynamic therapy and calcium death in tumor treatment. ACS Applied Materials & Interfaces, 2025,17(50):67655-67669. (2区, IF: 7.8)
(5)Y.N. Ou, Y.D. Wang, K.L. Chen, W.X. Liao, Z.M. Tang*. Triple-responsive cross-linked micelles for synergistic chemo-photothermal cancer therapy. Molecular Pharmaceutics, 2025,22(10):6357-6367. (2区, IF: 4.9)
(6)Z.M. Tang*, Q. He, J.R. Zhou, S. Yan, Li Jiang, Y.D. Wang, C.X. Yao, H.Z. Wei, K.D. Yang, J.J. Wang. Active-transporting of charge-reversal Cu(II)-doped mesoporous silica nanoagents for antitumor chemo/chemodynamic therapy. Chinese Chemical Letters, 2024, 35(7), 109742. (1区, IF: 9.1)
(7)Q.Y. Jin, D.Y. Ji, Y.H. Chen, Z.M. Tang*. Kinetics and pathway of levofloxacin degradation by ferrate(VI) and reaction mechanism of catalytic degradation by copper sulfide. Separation and Purification Technology, 2022, 282, 120104. (1区, IF: 9.1)
(8)Z.M. Tang*, S.T. Jiang, W.L. Tang, Q. He, H.Z. Wei, C.Y. Jin, S. Wang, H. Zhang. H2O2 self-supplying and GSH-depleting nanocatalyst for copper metabolism-based synergistic chemodynamic therapy and chemotherapy. Molecular Pharmaceutics, 2023, 20(3):1717-1728. (2区, IF: 4.9)
(9)H.Y. Long, W.J. Tian, S.T. Jiang, J.Q. Zhao, J.R. Zhou, Q. He, Z.M. Tang*. A dual drug delivery platform based on thermo-responsive polymeric micelle capped mesoporous silica nanoparticles for cancer therapy. Microporous and Mesoporous Materials, 2022, 338, 111943. (2区, IF: 4.5)
(10)Z.M. Tang*, W.J. Tian, H.Y. Long, S.T. Jiang, J.Q. Zhao, J.R. Zhou, Q. He, X. Luo. Subcellular-targeted NIR-responsive nanomedicine with synergistic chemo-photothermal therapy against multidrug resistant cancer. Molecular Pharmaceutics, 2022, 19(12):4538-4551. (2区, IF: 4.9)
(11)Z.M. Tang, Y.Q. Gao, D. Li, S.B. Zhou*. Controllably switched drug release from successively dual-targeted nanoreservoirs. Advanced Healthcare Materials, 2017, 6, 1600919. (2区, IF: 10.6)
(12)Z.M. Tang, L. Zhang, Y. Wang, D. Li, Z.D. Zhong, S.B. Zhou*. Redox-responsive star-shaped magnetic micelles with active-targeted and magnetic-guided functions for cancer therapy. Acta Biomaterialia, 2016, 42, 232-246. (1区, IF: 10.4)
(13)Z.M. Tang, D. Li, H.L. Sun, X. Guo, Y.P. Chen, S.B. Zhou*. Quantitative control of active targeting of nanocarriers to tumor cells through optimization of folate ligand density. Biomaterials, 2014, 35, 8015-8027. (1区, IF: 13.3)
3、代表性专利
(1)唐昭敏,廖文欣等,一种基于花瓣状MoS2的增强型复合纳米材料、制备方法及应用,ZL 202610197418.9
(2)唐昭敏,王郁东等,一种基于MOFs材料的增强型纳米复合催化剂、制备方法及应用,ZL 2024 1 1709183.4
(3)唐昭敏,何倩等,一种过渡金属基介孔纳米催化药物、制备方法及用途,ZL 2023 1 0599675.1
(4)唐昭敏,江舒婷等,一种多功能纳米催化剂及其制备方法,ZL 2022 1 0682380.6
4、学科竞赛
(1)荣获第三届全国高分子材料创新创业大赛银奖和铜奖,优秀指导教师
(2)荣获第四届四川省大学生材料设计大赛荣获三等奖
(3)指导国家级和省级创新创业训练计划4项,指导校级重点开放实验项目9项 |